BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 895 filers reported holding BAXTER INTL INC in Q1 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $27,000 | +17.4% | 700 | 0.0% | 0.00% | – |
| Q3 2015 | $23,000 | -100.0% | 700 | -100.0% | 0.00% | -100.0% |
| Q2 2015 | $122,449,000 | +10.1% | 1,751,019 | +7.8% | 2.08% | +14.3% |
| Q1 2015 | $111,215,000 | -0.9% | 1,623,579 | +6.0% | 1.82% | +0.4% |
| Q4 2014 | $112,210,000 | -3.1% | 1,531,036 | -5.1% | 1.81% | +12.4% |
| Q3 2014 | $115,822,000 | -1.2% | 1,613,800 | -0.5% | 1.61% | -2.2% |
| Q2 2014 | $117,271,000 | +0.9% | 1,622,000 | +2.7% | 1.65% | -3.5% |
| Q1 2014 | $116,212,000 | -1.0% | 1,579,400 | -6.4% | 1.70% | +3.8% |
| Q4 2013 | $117,393,000 | +37.3% | 1,687,900 | +29.6% | 1.64% | +30.3% |
| Q3 2013 | $85,522,000 | – | 1,301,900 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |